{"id":65976,"date":"2025-06-17T13:33:39","date_gmt":"2025-06-17T13:33:39","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=65976"},"modified":"2025-06-17T13:34:58","modified_gmt":"2025-06-17T13:34:58","slug":"latest-analyst-coverage-updates-june-17th-2025","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/","title":{"rendered":"Latest Analyst Coverage Updates: June 17th, 2025"},"content":{"rendered":"

Analyst Ratings-USA<\/a><\/h2>\n

Today’s analyst ratings reveal a cautiously optimistic market tone, with key upgrades in sectors like technology (e.g., Taboola, XPeng), healthcare (Cooper Companies), and energy (Comstock Resources), signaling investor confidence in select growth opportunities. At the same time, several downgrades\u2014particularly in real estate (FrontView REIT), semiconductors (Navitas), and renewables (Sunrun)\u2014highlight persistent sector-specific concerns and macro uncertainties. The blend of bullish and bearish revisions suggests a market in search of direction, as investors weigh company fundamentals against broader risks like interest rates and geopolitical tensions (Middle East). Overall, sentiment remains selective rather than broadly bullish.<\/p>\n

Latest Coverage Updates:<\/a><\/h2>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\n\n

Company Name<\/strong><\/h3>\n<\/td>\n

\n

Symbol<\/strong><\/h3>\n<\/td>\n

\n

Investment Bank<\/strong><\/h3>\n<\/td>\n

\n

Action<\/strong><\/h3>\n<\/td>\n

\n

Analyst Rating<\/strong><\/h3>\n<\/td>\n

\n

Target Price<\/strong><\/h3>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Acumen Pharmaceuticals<\/h4>\n<\/td>\n

\n

ABOS<\/h4>\n<\/td>\n

\n

Citigroup<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$4.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Adobe<\/h4>\n<\/td>\n

\n

ADBE<\/h4>\n<\/td>\n

\n

Citi<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$450.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Aeva Technologies<\/h4>\n<\/td>\n

\n

AEVA<\/h4>\n<\/td>\n

\n

Roth MKM<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$30.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Agco<\/h4>\n<\/td>\n

\n

AGCO<\/h4>\n<\/td>\n

\n

Truist Financial<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$112.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Alkermes<\/h4>\n<\/td>\n

\n

ALKS<\/h4>\n<\/td>\n

\n

UBS Group<\/h4>\n<\/td>\n

\n

Upgraded<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$42.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

American Express<\/h4>\n<\/td>\n

\n

AXP<\/h4>\n<\/td>\n

\n

TD Cowen<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$270.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Amylyx Pharmaceuticals<\/h4>\n<\/td>\n

\n

AMLX<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$12.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Apple<\/h4>\n<\/td>\n

\n

AAPL<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$210.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Aquestive Therapeutics<\/h4>\n<\/td>\n

\n

AQST<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$10.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Arcellx<\/h4>\n<\/td>\n

\n

ACLX<\/h4>\n<\/td>\n

\n

Citigroup<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$110.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

ArriVent BioPharma, Inc.<\/h4>\n<\/td>\n

\n

AVBP<\/h4>\n<\/td>\n

\n

JonesTrading<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$40.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Artivion<\/h4>\n<\/td>\n

\n

AORT<\/h4>\n<\/td>\n

\n

Canaccord Genuity Group<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$35.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Avidity Biosciences<\/h4>\n<\/td>\n

\n

RNA<\/h4>\n<\/td>\n

\n

Wolfe Research<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$55.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Belden<\/h4>\n<\/td>\n

\n

BDC<\/h4>\n<\/td>\n

\n

Benchmark<\/h4>\n<\/td>\n

\n

Target Raised<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$130.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

BGSF<\/h4>\n<\/td>\n

\n

BGSF<\/h4>\n<\/td>\n

\n

Roth MKM<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$8.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

BioLineRx<\/h4>\n<\/td>\n

\n

BLRX<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$26.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

BridgeBio Pharma<\/h4>\n<\/td>\n

\n

BBIO<\/h4>\n<\/td>\n

\n

Wolfe Research<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$60.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Camden Property Trust<\/h4>\n<\/td>\n

\n

CPT<\/h4>\n<\/td>\n

\n

JPMorgan Chase & Co.<\/h4>\n<\/td>\n

\n

Target Raised<\/h4>\n<\/td>\n

\n

Underweight<\/h4>\n<\/td>\n

\n

$129.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Cantaloupe<\/h4>\n<\/td>\n

\n

CTLP<\/h4>\n<\/td>\n

\n

B. Riley<\/h4>\n<\/td>\n

\n

Downgrades<\/h4>\n<\/td>\n

\n

Neutral<\/h4>\n<\/td>\n

\n

$11.20<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Cantaloupe<\/h4>\n<\/td>\n

\n

CTLP<\/h4>\n<\/td>\n

\n

Barrington<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Sell<\/h4>\n<\/td>\n

\n

$12.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Cardinal Health<\/h4>\n<\/td>\n

\n

CAH<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$185.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Carpenter Technology<\/h4>\n<\/td>\n

\n

CRS<\/h4>\n<\/td>\n

\n

JPMorgan Chase & Co.<\/h4>\n<\/td>\n

\n

Target Raised<\/h4>\n<\/td>\n

\n

Overweight<\/h4>\n<\/td>\n

\n

$305.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Centerspace<\/h4>\n<\/td>\n

\n

CSR<\/h4>\n<\/td>\n

\n

Colliers Securities<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$74.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

CNH Industrial<\/h4>\n<\/td>\n

\n

CNH<\/h4>\n<\/td>\n

\n

Truist Financial<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$16.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Coda Octopus Group<\/h4>\n<\/td>\n

\n

CODA<\/h4>\n<\/td>\n

\n

Alliance Global Partners<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$10.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Cogent Biosciences<\/h4>\n<\/td>\n

\n

COGT<\/h4>\n<\/td>\n

\n

Needham & Company LLC<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n\n

Coinbase Global<\/h4>\n<\/td>\n

\n

COIN<\/h4>\n<\/td>\n

\n

China Renaissance<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$353.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Comstock Resources<\/h4>\n<\/td>\n

\n

CRK<\/h4>\n<\/td>\n

\n

Wolfe Research<\/h4>\n<\/td>\n

\n

Upgraded<\/h4>\n<\/td>\n

\n

Outperform<\/h4>\n<\/td>\n

\n

$34.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Cooper Companies<\/h4>\n<\/td>\n

\n

COO<\/h4>\n<\/td>\n

\n

Needham & Company LLC<\/h4>\n<\/td>\n

\n

Upgraded<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$94.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Coty<\/h4>\n<\/td>\n

\n

COTY<\/h4>\n<\/td>\n

\n

Citi<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$6.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Coty<\/h4>\n<\/td>\n

\n

COTY<\/h4>\n<\/td>\n

\n

Evercore ISI<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$10.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Deere<\/h4>\n<\/td>\n

\n

DE<\/h4>\n<\/td>\n

\n

Truist Financial<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$619.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Disc Medicine<\/h4>\n<\/td>\n

\n

IRON<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$118.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Eli Lilly & Co<\/h4>\n<\/td>\n

\n

LLY<\/h4>\n<\/td>\n

\n

Bernstein<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$1,100.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

EOG Resources<\/h4>\n<\/td>\n

\n

EOG<\/h4>\n<\/td>\n

\n

Stephens<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$137.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Esperion Therapeutics<\/h4>\n<\/td>\n

\n

ESPR<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$16.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

FibroBiologics<\/h4>\n<\/td>\n

\n

FBLG<\/h4>\n<\/td>\n

\n

D. Boral Capital<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$16.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Fortinet<\/h4>\n<\/td>\n

\n

FTNT<\/h4>\n<\/td>\n

\n

Rosenblatt Securities<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$125.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

FrontView REIT<\/h4>\n<\/td>\n

\n

FVR<\/h4>\n<\/td>\n

\n

JPMorgan Chase & Co.<\/h4>\n<\/td>\n

\n

Downgrades<\/h4>\n<\/td>\n

\n

Neutral<\/h4>\n<\/td>\n

\n

$12.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

FrontView REIT, Inc.<\/h4>\n<\/td>\n

\n

FVR<\/h4>\n<\/td>\n

\n

J.P. Morgan<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$12.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Galectin Therapeutics<\/h4>\n<\/td>\n

\n

GALT<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$6.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Galp Energia SGPS SA<\/h4>\n<\/td>\n

\n

GLPEY<\/h4>\n<\/td>\n

\n

Bernstein<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

GMS Inc.<\/h4>\n<\/td>\n

\n

GMS<\/h4>\n<\/td>\n

\n

Royal Bank of Canada<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Sector Perform<\/h4>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n\n

GMS Inc.<\/h4>\n<\/td>\n

\n

GMS<\/h4>\n<\/td>\n

\n

Barclays<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Equal Weight<\/h4>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n\n

GMS Inc.<\/h4>\n<\/td>\n

\n

GMS<\/h4>\n<\/td>\n

\n

Robert W. Baird<\/h4>\n<\/td>\n

\n

Target Set<\/h4>\n<\/td>\n

\n

N\/A<\/h4>\n<\/td>\n

\n

$93.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

GMS Inc.<\/h4>\n<\/td>\n

\n

GMS<\/h4>\n<\/td>\n

\n

Truist Financial<\/h4>\n<\/td>\n

\n

Target Set<\/h4>\n<\/td>\n

\n

N\/A<\/h4>\n<\/td>\n

\n

$80.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Harmonic<\/h4>\n<\/td>\n

\n

HLIT<\/h4>\n<\/td>\n

\n

Rosenblatt Securities<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$11.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Health Catalyst<\/h4>\n<\/td>\n

\n

HCAT<\/h4>\n<\/td>\n

\n

BTIG Research<\/h4>\n<\/td>\n

\n

Downgrades<\/h4>\n<\/td>\n

\n

Neutral<\/h4>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n\n

Humana<\/h4>\n<\/td>\n

\n

HUM<\/h4>\n<\/td>\n

\n

Bernstein<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$313.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Immuneering<\/h4>\n<\/td>\n

\n

IMRX<\/h4>\n<\/td>\n

\n

Mizuho Securities<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$8.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Intercontinental Exchange<\/h4>\n<\/td>\n

\n

ICE<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$195.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Jasper Therapeutics<\/h4>\n<\/td>\n

\n

JSPR<\/h4>\n<\/td>\n

\n

H.C. Wainwright<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$40.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

JBS<\/h4>\n<\/td>\n

\n

JBS<\/h4>\n<\/td>\n

\n

Barclays<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$22.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Kinder Morgan<\/h4>\n<\/td>\n

\n

KMI<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$38.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Lyft<\/h4>\n<\/td>\n

\n

LYFT<\/h4>\n<\/td>\n

\n

TD Cowen<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$16.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Mayville Engineering<\/h4>\n<\/td>\n

\n

MEC<\/h4>\n<\/td>\n

\n

DA Davidson<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$23.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Meta Platforms<\/h4>\n<\/td>\n

\n

META<\/h4>\n<\/td>\n

\n

Evercore ISI<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$750.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Millicom International Cellular<\/h4>\n<\/td>\n

\n

TIGO<\/h4>\n<\/td>\n

\n

Scotiabank<\/h4>\n<\/td>\n

\n

Downgrades<\/h4>\n<\/td>\n

\n

Sector Perform<\/h4>\n<\/td>\n

\n

$37.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Monster Beverage<\/h4>\n<\/td>\n

\n

MNST<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$63.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Navitas Semiconductor<\/h4>\n<\/td>\n

\n

NVTS<\/h4>\n<\/td>\n

\n

Deutsche Bank Aktiengesellschaft<\/h4>\n<\/td>\n

\n

Downgrades<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$3.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

NewAmsterdam Pharma<\/h4>\n<\/td>\n

\n

NAMS<\/h4>\n<\/td>\n

\n

Citigroup<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$42.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Newell Brands<\/h4>\n<\/td>\n

\n

NWL<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$5.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

NIKE<\/h4>\n<\/td>\n

\n

NKE<\/h4>\n<\/td>\n

\n

Telsey Advisory Group<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Market Perform<\/h4>\n<\/td>\n

\n

$70.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Nio Inc.<\/h4>\n<\/td>\n

\n

NIO<\/h4>\n<\/td>\n

\n

The Goldman Sachs Group<\/h4>\n<\/td>\n

\n

Upgraded<\/h4>\n<\/td>\n

\n

Neutral<\/h4>\n<\/td>\n

\n

$3.80<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Novavax<\/h4>\n<\/td>\n

\n

NVAX<\/h4>\n<\/td>\n

\n

Citigroup<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Sell<\/h4>\n<\/td>\n

\n

$6.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Nutrien Ltd.<\/h4>\n<\/td>\n

\n

NTR<\/h4>\n<\/td>\n

\n

Raymond James<\/h4>\n<\/td>\n

\n

Downgrades<\/h4>\n<\/td>\n

\n

Market Perform<\/h4>\n<\/td>\n

\n

$68.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

ON Semiconductor<\/h4>\n<\/td>\n

\n

ON<\/h4>\n<\/td>\n

\n

Roth MKM<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$70.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

OneMain Holdings<\/h4>\n<\/td>\n

\n

OMF<\/h4>\n<\/td>\n

\n

TD Cowen<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$56.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Perpetua Resources<\/h4>\n<\/td>\n

\n

PPTA<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$27.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Protagonist Therapeutics<\/h4>\n<\/td>\n

\n

PTGX<\/h4>\n<\/td>\n

\n

Citigroup<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$72.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

ReNew Energy Global<\/h4>\n<\/td>\n

\n

RNW<\/h4>\n<\/td>\n

\n

Roth MKM<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$7.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Rocket Pharmaceuticals<\/h4>\n<\/td>\n

\n

RCKT<\/h4>\n<\/td>\n

\n

Wedbush<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$16.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Roku<\/h4>\n<\/td>\n

\n

ROKU<\/h4>\n<\/td>\n

\n

Needham & Company LLC<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$88.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Roku<\/h4>\n<\/td>\n

\n

ROKU<\/h4>\n<\/td>\n

\n

Loop Capital<\/h4>\n<\/td>\n

\n

Upgraded<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$100.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sage Therapeutics<\/h4>\n<\/td>\n

\n

SAGE<\/h4>\n<\/td>\n

\n

Canaccord Genuity Group<\/h4>\n<\/td>\n

\n

Target Raised<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$8.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

SAGE Therapeutics<\/h4>\n<\/td>\n

\n

SAGE<\/h4>\n<\/td>\n

\n

Piper Sandler<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$8.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

SAGE Therapeutics<\/h4>\n<\/td>\n

\n

SAGE<\/h4>\n<\/td>\n

\n

TD Cowen<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$8.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sarepta Therapeutics<\/h4>\n<\/td>\n

\n

SRPT<\/h4>\n<\/td>\n

\n

TD Cowen<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$62.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sarepta Therapeutics<\/h4>\n<\/td>\n

\n

SRPT<\/h4>\n<\/td>\n

\n

Wolfe Research<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$90.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sarepta Therapeutics<\/h4>\n<\/td>\n

\n

SRPT<\/h4>\n<\/td>\n

\n

Morgan Stanley<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$40.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sarepta Therapeutics<\/h4>\n<\/td>\n

\n

SRPT<\/h4>\n<\/td>\n

\n

Jefferies<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$54.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sarepta Therapeutics<\/h4>\n<\/td>\n

\n

SRPT<\/h4>\n<\/td>\n

\n

Cantor Fitzgerald<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$20.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sarepta Therapeutics<\/h4>\n<\/td>\n

\n

SRPT<\/h4>\n<\/td>\n

\n

UBS<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$85.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Shell<\/h4>\n<\/td>\n

\n

SHEL<\/h4>\n<\/td>\n

\n

Bernstein<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

\n

$76.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Silicon Motion<\/h4>\n<\/td>\n

\n

SIMO<\/h4>\n<\/td>\n

\n

Roth MKM<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$90.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

SolarEdge Technologies<\/h4>\n<\/td>\n

\n

SEDG<\/h4>\n<\/td>\n

\n

Glj Research<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Sell<\/h4>\n<\/td>\n

\n

$6.90<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Solid Biosciences<\/h4>\n<\/td>\n

\n

SLDB<\/h4>\n<\/td>\n

\n

HC Wainwright<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$20.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Sunrun<\/h4>\n<\/td>\n

\n

RUN<\/h4>\n<\/td>\n

\n

Glj Research<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Sell<\/h4>\n<\/td>\n

\n

<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Supernus Pharmaceuticals<\/h4>\n<\/td>\n

\n

SUPN<\/h4>\n<\/td>\n

\n

TD Cowen<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$45.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Taboola.com<\/h4>\n<\/td>\n

\n

TBLA<\/h4>\n<\/td>\n

\n

Needham & Company LLC<\/h4>\n<\/td>\n

\n

Target Raised<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$4.50<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Theravance Biopharma<\/h4>\n<\/td>\n

\n

TBPH<\/h4>\n<\/td>\n

\n

Jones Trading<\/h4>\n<\/td>\n

\n

Initiates<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$24.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Theravance Biopharma<\/h4>\n<\/td>\n

\n

TBPH<\/h4>\n<\/td>\n

\n

JonesTrading<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$24.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

TotalEnergies<\/h4>\n<\/td>\n

\n

TTE<\/h4>\n<\/td>\n

\n

Bernstein<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$63.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

TransMedics Group<\/h4>\n<\/td>\n

\n

TMDX<\/h4>\n<\/td>\n

\n

Needham & Company LLC<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Hold<\/h4>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n\n

Vertex<\/h4>\n<\/td>\n

\n

VERX<\/h4>\n<\/td>\n

\n

Piper Sandler<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$48.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Visa<\/h4>\n<\/td>\n

\n

V<\/h4>\n<\/td>\n

\n

Truist Financial<\/h4>\n<\/td>\n

\n

Target Update<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$400.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

Wingstop<\/h4>\n<\/td>\n

\n

WING<\/h4>\n<\/td>\n

\n

TD Securities<\/h4>\n<\/td>\n

\n

Maintains<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$440.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

XPeng<\/h4>\n<\/td>\n

\n

XPEV<\/h4>\n<\/td>\n

\n

The Goldman Sachs Group<\/h4>\n<\/td>\n

\n

Upgraded<\/h4>\n<\/td>\n

\n

Buy<\/h4>\n<\/td>\n

\n

$24.00<\/h4>\n<\/td>\n

<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings-USA Today’s analyst ratings reveal a cautiously optimistic market tone, with key upgrades in sectors like technology (e.g., Taboola, XPeng), healthcare (Cooper Companies), and…<\/p>\n","protected":false},"author":3,"featured_media":40676,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-65976","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nLatest Analyst Coverage Updates: June 17th, 2025 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Latest Analyst Coverage Updates: June 17th, 2025\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings-USA Today’s analyst ratings reveal a cautiously optimistic market tone, with key upgrades in sectors like technology (e.g., Taboola, XPeng), healthcare (Cooper Companies), and...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-17T13:33:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-17T13:34:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/09\/untitled-design-2023-09-28T130014.002.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Latest Analyst Coverage Updates: June 17th, 2025\",\"datePublished\":\"2025-06-17T13:33:39+00:00\",\"dateModified\":\"2025-06-17T13:34:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\"},\"wordCount\":847,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\",\"name\":\"Latest Analyst Coverage Updates: June 17th, 2025 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2025-06-17T13:33:39+00:00\",\"dateModified\":\"2025-06-17T13:34:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Latest Analyst Coverage Updates: June 17th, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Latest Analyst Coverage Updates: June 17th, 2025 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/","og_locale":"en_US","og_type":"article","og_title":"Latest Analyst Coverage Updates: June 17th, 2025","og_description":"Analyst Ratings-USA Today’s analyst ratings reveal a cautiously optimistic market tone, with key upgrades in sectors like technology (e.g., Taboola, XPeng), healthcare (Cooper Companies), and...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2025-06-17T13:33:39+00:00","article_modified_time":"2025-06-17T13:34:58+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/09\/untitled-design-2023-09-28T130014.002.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Latest Analyst Coverage Updates: June 17th, 2025","datePublished":"2025-06-17T13:33:39+00:00","dateModified":"2025-06-17T13:34:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/"},"wordCount":847,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/","name":"Latest Analyst Coverage Updates: June 17th, 2025 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2025-06-17T13:33:39+00:00","dateModified":"2025-06-17T13:34:58+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/latest-analyst-coverage-updates-june-17th-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Latest Analyst Coverage Updates: June 17th, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/65976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=65976"}],"version-history":[{"count":11,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/65976\/revisions"}],"predecessor-version":[{"id":65990,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/65976\/revisions\/65990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/40676"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=65976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=65976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=65976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}